Evidence map›Paper›PMID 23463364›Full record

ArticleHepatology (Baltimore, Md.)2013

Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection.

Jens Martin Werner, Theo Heller, Ann Marie Gordon, Arlene Sheets, Averell H Sherker, Ellen Kessler, Kathleen S Bean, M'Lou Stevens, James Schmitt, Barbara Rehermann

Open access · greenAbstract read
In one paragraph

Article in Hepatology (Baltimore, Md.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Control of HCV Infection by Natural Killer Cells and Macrophages.Cold Spring Harbor perspectives in medicine · 2020
    Review
  10. Article
  11. Article
  12. NKT cells in liver diseases.Frontiers of medicine · 2018
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Natural Killer Cells in Antifungal Immunity.Frontiers in immunology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jens Martin WernerLiver Diseases Branch, NIDDK, National Institutes of Health, DHHS, Bethesda, MD.
Theo Heller
Ann Marie Gordon
Arlene Sheets
Averell H Sherker
Ellen Kessler
Kathleen S Bean
M'Lou Stevens
James Schmitt
Barbara Rehermann
National Institutes of Health · USMedStar Washington Hospital Center · USInova Fairfax Hospital · USNational Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

Regulation of hepatic and systemic immune responsesZIADK054508 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI REHERMANN, BARBARA · 2009 to 2025
$22.1M
Immunology of Acute and Chronic Viral Hepatitis in HumansZIADK054509 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI REHERMANN, BARBARA · 2009 to 2025
$15.1M
Investigation of management and disease manifestations of viral hepatitisZIADK054514 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HELLER, THEO · 2009 to 2025
$12.9M
Role of the innate immune defenses in viral infectionsZIADK054516 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI REHERMANN, BARBARA · 2009 to 2023
$11.3M
Intramural NIH HHS ZIA DK054508Intramural NIH HHS ZIA DK054509Intramural NIH HHS ZIA DK054516
6 · The paper itself

Abstract

unlabelledHepatitis C virus (HCV) infection typically results in chronic disease with HCV outpacing antiviral immune responses. Here we asked whether innate immune responses are induced in healthcare workers who are exposed to small amounts of HCV, but do not develop systemic infection and acute liver disease. Twelve healthcare workers with accidental percutaneous exposure to HCV-infected blood were prospectively studied for up to 6 months for phenotype and function of natural killer T (NKT) and NK cells, kinetics of serum chemokines, and vigor and specificity of HCV-specific T-cell responses. Eleven healthcare workers tested negative for HCV RNA and HCV antibodies. All but one of these aviremic cases displayed NKT cell activation, increased serum chemokines levels, and NK cell responses with increased CD122, NKp44, NKp46, and NKG2A expression, cytotoxicity (as determined by TRAIL and CD107a expression), and interferon-gamma (IFN-γ) production. This multifunctional NK cell response appeared a month earlier than in the one healthcare worker who developed high-level viremia, and it differed from the impaired IFN-γ production, which is typical for NK cells in chronic HCV infection. The magnitude of NKT cell activation and NK cell cytotoxicity correlated with the magnitude of the subsequent HCV-specific T-cell response. T-cell responses targeted nonstructural HCV sequences that require translation of viral RNA, which suggests that transient or locally contained HCV replication occurred without detectable systemic viremia.

conclusionExposure to small amounts of HCV induces innate immune responses, which correlate with the subsequent HCV-specific T-cell response and may contribute to antiviral immunity.

Indexed as

Health PersonnelImmunity, InnateOccupational ExposureAcute DiseaseAdaptive ImmunityAdultAgedChemokine CCL3FemaleHepatitis CHumansInterleukin-2 Receptor beta SubunitMaleMiddle AgedNatural Killer T-CellsProspective StudiesCCL3 protein, humanChemokine CCL3Interleukin-2 Receptor beta SubunitTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, human

Identifiers

PMID23463364
PMCPMC3688637
OpenAlexW2108794117

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.